BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7631029)

  • 1. The explanation for the influence of prescription habits on radiation dose-time parameters for head and neck tumour control.
    Hendry JH; Roberts SA; Slevin NJ
    Radiother Oncol; 1995 Mar; 34(3):228-9. PubMed ID: 7631029
    [No Abstract]   [Full Text] [Related]  

  • 2. Local control, TCD50 and dose-time prescription habits in radiotherapy of head and neck tumours.
    Dubben HH
    Radiother Oncol; 1994 Sep; 32(3):197-200. PubMed ID: 7816938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose rate teletherapy and tumour response.
    Hamilton CS; Denham JW
    Australas Radiol; 1994 Feb; 38(1):85. PubMed ID: 8147814
    [No Abstract]   [Full Text] [Related]  

  • 4. No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours.
    Dubben HH
    Radiother Oncol; 1992 Oct; 25(2):142-3. PubMed ID: 1438933
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-response relations for stricture in the proximal oesophagus from head and neck radiotherapy.
    Alevronta E; Ahlberg A; Mavroidis P; al-Abany M; Friesland S; Tilikidis A; Laurell G; Lind BK
    Radiother Oncol; 2010 Oct; 97(1):54-9. PubMed ID: 20557965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-time factors in head and neck data.
    Taylor JM; Withers HR
    Radiother Oncol; 1992 Dec; 25(4):313-5. PubMed ID: 1480779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The time factor and time-dose-prescription in the radiotherapy of head and neck tumors].
    Dubben HH
    Strahlenther Onkol; 1994 Feb; 170(2):101-2. PubMed ID: 8108774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall treatment time and tumor control dose for head and neck tumors: the dog leg revisited.
    Bentzen SM; Thames HD
    Radiother Oncol; 1992 Oct; 25(2):143-4. PubMed ID: 1438934
    [No Abstract]   [Full Text] [Related]  

  • 9. [External beam irradiation of head and neck cancer].
    Heinze F; Röttinger EM
    Laryngorhinootologie; 2006 Mar; 85(3):209-22; quiz 223-7. PubMed ID: 16547899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General reactions during radiation therapy of various malignant head and neck neoplasms].
    Limarova IV
    Med Radiol (Mosk); 1977 Sep; 22(9):71-2. PubMed ID: 927077
    [No Abstract]   [Full Text] [Related]  

  • 11. Low dose rate teletherapy: updated tumour response.
    Denham JW; Hamilton CS; Simpson SA; O'Brien M
    Australas Radiol; 1996 May; 40(2):155-7. PubMed ID: 8687349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose escalation, treatment protraction, and the steepness of the dose-response curve for squamous cell carcinoma of the head and neck.
    Yaes RJ
    Radiother Oncol; 1995 Jan; 34(1):81-3. PubMed ID: 7792405
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiotherapy with three fractions per day for twelve consecutive days for tumors of the thorax, head and neck.
    Saunders MI; Dische S; Fowler JF; Denekamp J; Dunphy EP; Grosch E; Fermont D; Ashford R; Maher J; Des Rochers C
    Front Radiat Ther Oncol; 1988; 22():99-104. PubMed ID: 3350356
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiotherapy--new fractionation schemes.
    Dische S
    Semin Oncol; 1994 Jun; 21(3):304-10. PubMed ID: 8209263
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues.
    Hendry JH
    Radiother Oncol; 1992 Dec; 25(4):308-12. PubMed ID: 1480778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interfraction interval and dose-response in RTOG trials--regarding Fu et al., IJROBP 32:577-588; 1995.
    Withers HR; Taylor JM
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):887-8. PubMed ID: 7790277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities in current radiotherapy of head and neck malignancies].
    Frommhold H
    Rontgenblatter; 1989 May; 42(5):216-8. PubMed ID: 2756306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
    Grégoire V
    Rays; 2005; 30(2):105-8. PubMed ID: 16294902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative irradiation for squamous cell carcinomas of the head and neck: analysis of time-dose factors related to control above the clavicles.
    Marcus RB; Million RR; Cassissi NJ
    Int J Radiat Oncol Biol Phys; 1979; 5(11-12):1943-9. PubMed ID: 544572
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose painting: art or science?
    Tanderup K; Olsen DR; Grau C
    Radiother Oncol; 2006 Jun; 79(3):245-8. PubMed ID: 16725221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.